Erin Duffy, PhD, is the Chief of Research & Development at CARB-X, a global biopharmaceutical accelerator for the discovery and early development of products to prevent, diagnose and treat bacterial infections. Erin is an expert in drug discovery and problem solving in the antibiotic arena. Most of her professional growth was with Melinta Therapeutics (founded as Rib-X Pharmaceuticals), where over 17 years she became Executive Vice President, Chief Scientific Officer and R&D site head. Her entry into the pharmaceutical sector began with Pfizer Central Research. Erin’s formal training was at Yale University, where she completed a PhD in physical-organic chemistry and an HHMI postdoctoral fellowship in computational structural biology.